Skip to main content

NSE:AUROPHARMA Stock Forecast, Price Targets (Buy or Sell) | AUROPHARMA Aurobindo Pharma Limited Analyst Ratings

Additionally, we exclude revolver borrowing availability that we believe would be inaccessible due to covenant constraints. For revolving credit facilities with extension options, we include the extension period(s) under sources of liquidity only if the option is at the discretion of the borrower. If lenders have the option to terminate commitments at each extension point, we only include the borrowing availability under the facility up to the first extension date.

We estimate AUROPHARMA Aurobindo Pharma Limited stock forecast parameters by: Triple Exponential Moving Average (TRIX) with Sign Test

AUROPHARMA Aurobindo Pharma Limited Stock Forecast (Buy or Sell) as of 19 Apr 2022 for (n+1y)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Triple Exponential Moving Average (TRIX) and Sign Test. Machine Learning based stock forecast (n+1y) for AUROPHARMA Aurobindo Pharma Limited as below:

Time series to forecast n: 19 Apr 2022 for (n+1y)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %

 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |